Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$4.0 million.

  • Traws Pharma's Profit After Tax rose 5325.07% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.3 million, marking a year-over-year increase of 9054.66%. This contributed to the annual value of -$166.5 million for FY2024, which is 77884.21% down from last year.
  • Traws Pharma's Profit After Tax amounted to -$4.0 million in Q3 2025, which was up 5325.07% from -$915000.0 recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Profit After Tax registered a high of $21.5 million during Q1 2025, and its lowest value of -$123.1 million during Q2 2024.
  • Moreover, its 5-year median value for Profit After Tax was -$4.2 million (2023), whereas its average is -$10.7 million.
  • Per our database at Business Quant, Traws Pharma's Profit After Tax tumbled by 279748.24% in 2024 and then soared by 53126.63% in 2025.
  • Over the past 5 years, Traws Pharma's Profit After Tax (Quarter) stood at -$3.8 million in 2021, then plummeted by 44.0% to -$5.4 million in 2022, then increased by 22.8% to -$4.2 million in 2023, then plummeted by 615.15% to -$29.9 million in 2024, then surged by 86.76% to -$4.0 million in 2025.
  • Its Profit After Tax was -$4.0 million in Q3 2025, compared to -$915000.0 in Q2 2025 and $21.5 million in Q1 2025.